Lucid Diagnostics Inc.LUCDNASDAQ
LOADING
|||
Year-over-year research & development expense growth
| Period | Value |
|---|---|
| Q3 2025 | 101254.58% |
| Q2 2025 | -12.11% |
| Q1 2025 | -1.72% |
| Q4 2024 | -12.79% |
| Q3 2024 | 21.43% |
| Q2 2024 | -8.59% |
| Q1 2024 | -21.74% |
| Q4 2023 | 18.76% |
| Q3 2023 | -11.60% |
| Q2 2023 | -3.49% |
| Q1 2023 | -22.48% |
| Q4 2022 | -9.69% |
| Q3 2022 | -21.40% |
| Q2 2022 | 19.40% |
| Q1 2022 | -17.26% |
| Q4 2021 | 59.00% |
| Q3 2021 | 16.92% |
| Q2 2021 | 6.91% |
| Q1 2021 | -4.05% |
| Q4 2020 | 50.12% |
| Q3 2020 | 40.41% |
| Q2 2020 | -43.53% |
| Q1 2020 | -15.81% |
| Q4 2019 | 0.00% |
| Q4 2018 | 0.00% |